Philip Morris International has doubled its planned investment in its Colorado manufacturing campus to about $1.2 billion through 2028, as it expands production capacity for the Zyn nicotine pouch business.
Expansion Details
The company had initially announced a $600 million investment to build a manufacturing facility for Zyn nicotine pouches in Aurora, which opened on Monday. The facility produces Zyn nicotine pouches and will support exports to markets across Asia, Latin America, and the Caribbean.
Once fully operational, the facility is expected to generate approximately $550 million in annual economic impact and support 1,000 indirect jobs, the company said. The investment comes weeks after the U.S. Food and Drug Administration authorized 20 Zyn nicotine pouches as less harmful than cigarettes, allowing the company to market reduced-risk information compared with cigarettes.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
